Please login to the form below

Not currently logged in

Excellence in Healthcare Professional Education and Support Programmes

Sponsored by

Back to Results


Creating a Movement in Dermatology: CLEAR HORIZONS UK

by AbbVie
with support from Lucid Group

Summary of work

In moderate-severe psoriasis, IL-23 inhibitors (IL-23i) are ground-breaking in terms of durable efficacy and favourable safety. However, uptake in the UK faces unique challenges, including risk aversion to biologic use; lack of experience with SKYRIZI, a new IL-23i; and the COVID-19 pandemic. Following the launch of SKYRIZI mid-2019, the Commercial CLEAR HORIZONS TV and Peer Podcast Series (CHTV-PPS) was designed to establish an IL-23 expert community to connect, share expertise and drive change in clinical practice at a local level via a customer engagement experience that maximised virtual engagement with the dermatology community.
A committed and influential group of 5 UK change leaders helped to co-create CHTV-PPS, reaching >1300 UK dermatologists. By providing experiential education via an accessible and fresh virtual approach, CHTV-PPS is unique in enabling UK healthcare professionals to share knowledge and enthusiasm for improving patient outcomes with IL-23is. Results demonstrate that, despite COVID-19 reducing clinic attendance, IL-23is show significant growth – including new SKYRIZI prescriptions as a direct result of CHTV-PPS. By establishing a bigger, more united and inspired community than ever before, CHTV-PPS has encouraged most partaking dermatologists and nurses to change clinical practice, ultimately transforming patients’ lives.

Judges' comments

The Clear Horizons submission showed an excellent understanding of customers, which translated into behavioural change. They showed dynamic adaptation during the execution and it has a really powerful message. The judges liked the good value metrics and the strong articulation around reach and impact. There was a strong thread through all the criteria and the strategy was clear, with adaption to working through COVID.

Highly commended

IBD Empower: an Innovative Approach to Specialist Nurse Education - by Takeda UK
with support from Immaculate, FCB Health London and Flipside


Creating a Movement in Dermatology: CLEAR HORIZONS UK - by AbbVie
with support from Lucid Group

Optimising Care in Severe Asthma - by AstraZeneca
with support from Patient Connect

Very Brief Advice for Tobacco Dependency - by Pfizer
with support from EPG Health

Key dates

Entry deadline 26 August 2022
Extended entry deadline 2 September 2022*
*additional fee applies
Judging Day 6 October 2022
Company/Team of the Year Interviews 21 October 2022
PMEA Event 23 November 2022